Company press releases and official corporate announcements.
A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.
18,845 total articles
Vertex, Inc., a global leader in tax and compliance technology, announced it will release its first quarter 2026 financial results on May 7, 2026, prior to market open, followed by a conference call at 8:30 a.m. ET. The company provides AI-driven tax automation solutions for enterprises worldwide, aiming to simplify compliance complexity.
Gevo, Inc., a NASDAQ-listed leader in renewable fuels and carbon management, has appointed Joan Cetera as Vice President of Communications and Public Relations. With over 20 years of experience in enterprise communications for public companies, Cetera will oversee Gevo's internal and external communications to support the company's strategic advanc…
Revolution Medicines, a late-stage oncology company targeting RAS-addicted cancers, announced its intention to offer $750 million of common stock and $250 million of convertible senior notes due 2033 in separate public offerings. The company plans to use proceeds for research and development, commercialization expenses, general and administrative c…
3 E Network Technology Group Limited announced a strategic blueprint led by VP Siyang Hu to develop a vertically integrated ecosystem for AI semiconductor and compute infrastructure. The plan includes leveraging both Arm and x86 architectures, focusing on AI all-flash scenarios, and building a full-stack software-hardware-compute center integration…
Celldex Therapeutics announced that its management will present and participate in a fireside chat at the upcoming H.C. Wainwright Inflammatory Skin Disease Virtual Conference. The event will be webcast and replays will be available for 90 days, highlighting Celldex's commitment to advancing novel antibody-based immunology therapies targeting aller…
Dorman Products, Inc. will report its first quarter 2026 financial results after Nasdaq market close on May 4, 2026, with a conference call scheduled for May 5, 2026. The company, a U.S.-based manufacturer of aftermarket automotive replacement products, continues to provide solutions for cars, trucks, and specialty vehicles globally.
NervGen Pharma Corp. (NASDAQ: NGEN), a clinical-stage biopharmaceutical company focused on developing neuroreparative therapeutics for spinal cord injury and other neurological conditions, announced its participation in the H.C. Wainwright HCW@Home series and the 2026 Bloom Burton & Co. Healthcare Investor Conference. The presentations will highlig…
Firefly Neuroscience, Inc. (NASDAQ: AIFF) announced surpassing 200,000 standardized EEG/ERP brain scans, marking a significant milestone in its data-driven approach to advancing AI-powered brain health diagnostics. The company recorded sequential quarterly growth in brain scan volumes and utilizes NVIDIA L40S GPU acceleration to enhance EEG/ERP pro…
Chemed Corporation has entered into an amended and restated five-year revolving credit agreement valued at $450 million, including a $100 million letter of credit component. The agreement features a floating interest rate based on SOFR plus a tiered rate dependent on leverage and includes an expansion option to increase the credit facility by $250 …
Ocean Power Technologies (OPTT) has deployed its first autonomous PowerBuoy system off the California coast under a contract with the U.S. Department of Homeland Security. This deployment supports maritime domain awareness and security operations for the U.S. Coast Guard, marking a significant milestone in providing persistent offshore power, commu…
Alpha Modus Holdings, Inc. has executed an agreement to convert 90% of its remaining Series C Preferred Stock into common equity, primarily owned by the CEO's family trusts. This strategic move simplifies the company's capital structure by removing legacy preferred stock features, reducing stockholders' deficit, and supporting compliance with Nasda…
Safe Pro Group Inc. has commenced commercial rollout of its NODE-X, a next-generation miniaturized AI-powered edge compute processor designed for real-time drone footage analysis to detect military threats. NODE-X integrates Safe Pro's patented SPOTD technology, providing advanced 3D mapping and threat detection capabilities at U.S. Army exercises,…
Datacentrex, Inc. reported full year 2025 financial results showing revenue of approximately $7 million and positive adjusted EBITDA of approximately $0.5 million despite substantial one-time merger costs. The company completed a $20.2 million public offering, resulting in over $59 million in cash and digital assets as of April 2026, positioning it…
Rezolve Ai has launched its proprietary brainpowa™ commerce-tuned AI models within Microsoft Foundry, joining foundational providers such as OpenAI and Anthropic. These models empower global brands to deploy commerce-specific AI copilots on Azure, designed to understand buying intent, orchestrate actions, and increase sales conversion. Integration …
Rezolve Ai announced an upcoming investor call to discuss its proposed combination with Commerce.com, highlighting significant growth prospects and synergy opportunities. Rezolve Ai projects a strong 7.5x revenue growth in 2026 with raised guidance, while integrating Commerce.com's extensive merchant network is expected to accelerate payment soluti…
Praxis Precision Medicines revealed expanded analyses from its Phase 3 Essential3 program demonstrating positive results for ulixacaltamide, a novel treatment for essential tremor. Ulixacaltamide has received FDA Breakthrough Therapy Designation. The company will present extensive data from its CNS-focused pipeline at the 2026 AAN Annual Meeting, u…
BioAge Labs, a clinical-stage biotechnology company targeting aging biology for metabolic diseases, announced its participation in the 25th Annual Needham Virtual Healthcare Conference, with presentations and meetings discussing their pipeline including the Phase 1 trial of their lead candidate BGE-102 targeting cardiovascular and retinal diseases.
Neuronetics, Inc. announced that Optum/United Healthcare/United Behavioral Health updated its Transcranial Magnetic Stimulation (TMS) policy to allow psychiatric mental health nurse practitioners (PMHNPs) in states with full practice authority to order and administer NeuroStar TMS therapy, significantly expanding patient access across 26 states and…
Lakeland Industries, a Nasdaq-listed company specializing in protective clothing and apparel, has promoted Kevin Rae to Executive Vice President, EMEA Fire Sales. Rae, with over 20 years experience in PPE and fire safety, will oversee the company's Fire business in Europe, the Middle East, and Africa, including the Eagle, Jolly, and LHD brands. Thi…
LM Funding America, a Nasdaq-listed Bitcoin treasury and mining company, announced improved operational performance for March 2026, including a record 9.6 Bitcoins mined and the highest hashrate achieved to date. The company expanded its mining fleet with 300 new Bitmain S19 XP miners, particularly at the Oklahoma facility. A renegotiated $11 milli…
Spyre Therapeutics, a clinical-stage biotechnology company focused on antibody engineering for inflammatory bowel disease (IBD) and other immune-mediated diseases, announced a proposed public offering of $300 million in common stock with an option for underwriters to purchase an additional $45 million. The offering is subject to market conditions a…
Burke & Herbert Financial Services Corp. and LINKBANCORP, Inc. have announced the receipt of all necessary regulatory approvals for their merger, expected to close on May 1, 2026. This merger combines two community-focused banks serving the Mid-Atlantic region, enhancing financial offerings across Delaware, Pennsylvania, Maryland, Virginia, West Vi…
ImmuCell Corporation has appointed Dr. Gilles Guillemette and Dr. Anthony DiMarco to its Board of Directors and is restructuring its board to seven members mostly independent. The company has created a Strategy and Technology Committee to support innovation and growth, particularly focusing on its flagship First Defense® product line that improves …
ALX Oncology has appointed Jeff Knight as Chief Development and Operating Officer. Knight brings over 30 years of industry experience in clinical development and operations, particularly in oncology. His leadership will support ALX Oncology's growth and execution of critical clinical milestones in their cancer therapy pipeline, including evorpacept…
Heartflow, Inc., a Nasdaq-listed leader in AI technology for coronary artery disease, has filed a patent infringement lawsuit against Cleerly, alleging unauthorized use of six patented technologies. The lawsuit seeks injunctive relief and damages, emphasizing Heartflow's commitment to protecting its intellectual property in cardiovascular AI applic…
